SCHEMBL2510147

SCHEMBL2510147

CCc1ccc2nc(C)c(C(=O)O)c(N)c2c1OCC(C)(C)NC(=O)c1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 5/20 0.34
GAA P10253 3/20 0.34
MEN1 O00255 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
GLA P06280 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
SSTR4 P31391 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX12 P18054 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2513153 0.91 MEN1 (0.34) NPC1RAB9AKMT2AMEN1L3MBTL1
SCHEMBL2511002 0.89 NPSR1 (0.38) RAB9AKMT2AMEN1KDM4EALDH1A1
SCHEMBL618130 0.85 KMT2A (0.38) NPC1RAB9APKMKMT2AGAA
SCHEMBL2511579 0.85 KDM4E (0.37) NPC1RAB9APKMKMT2AMEN1
SCHEMBL2512460 0.84 HSD17B1 (0.32)
SCHEMBL627058 0.84 SSTR4 (0.41) SSTR4
SCHEMBL2516719 0.83 KMT2A (0.33) KMT2AMEN1KDM4ESMN1; SMN2NPSR1
SCHEMBL2515079 0.83 TSHR (0.32) KMT2AMEN1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL2511738 0.83 MAP4K4 (0.32) KMT2AMEN1
SCHEMBL2512721 0.82 MAP4K4 (0.36) RAB9AKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8592592-B2 Sweet flavor modifier SENOMYX, INC. (US) 2013-11-26 US disclosed
US-20110245353-A1 SWEET FLAVOR MODIFIER SENOMYS, INC. (US) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245353-A1 SWEET FLAVOR MODIFIER TAS2R5, TAS2R10, TAS2R50 NPC1 1178/4885RAB9A 2382/4885PKM 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.